HEADER OXIDOREDUCTASE 14-JAN-17 5MUT TITLE CRYSTAL STRUCTURE OF POTENT HUMAN DIHYDROOROTATE DEHYDROGENASE TITLE 2 INHIBITORS BASED ON HYDROXYLATED AZOLE SCAFFOLDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DHODEHASE,DIHYDROOROTATE OXIDASE; COMPND 5 EC: 1.3.5.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DHODH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-19B KEYWDS DHODH, HUMAN DHODH, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR P.GOYAL,M.ANDERSSON,A.C.MORITZER,S.SAINAS,A.C.PIPPIONE,D.BOSCHI,S.AL- AUTHOR 2 KADARAGHI,M.LOLLI,R.FRIEMANN REVDAT 2 17-JAN-24 5MUT 1 REMARK REVDAT 1 08-MAR-17 5MUT 0 JRNL AUTH S.SAINAS,A.C.PIPPIONE,M.GIORGIS,E.LUPINO,P.GOYAL, JRNL AUTH 2 C.RAMONDETTI,B.BUCCINNA,M.PICCININI,R.C.BRAGA,C.H.ANDRADE, JRNL AUTH 3 M.ANDERSSON,A.C.MORITZER,R.FRIEMANN,S.MENSA,S.AL-KADARAGHI, JRNL AUTH 4 D.BOSCHI,M.L.LOLLI JRNL TITL DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION AND X-RAY JRNL TITL 2 STRUCTURAL STUDIES OF POTENT HUMAN DIHYDROOROTATE JRNL TITL 3 DEHYDROGENASE INHIBITORS BASED ON HYDROXYLATED AZOLE JRNL TITL 4 SCAFFOLDS. JRNL REF EUR J MED CHEM V. 129 287 2017 JRNL REFN ISSN 1768-3254 JRNL PMID 28235702 JRNL DOI 10.1016/J.EJMECH.2017.02.017 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 59767 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 2910 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.8102 - 4.8192 1.00 2898 148 0.1726 0.1953 REMARK 3 2 4.8192 - 3.8287 1.00 2772 143 0.1484 0.1696 REMARK 3 3 3.8287 - 3.3458 1.00 2756 135 0.1453 0.1768 REMARK 3 4 3.3458 - 3.0403 1.00 2706 155 0.1587 0.1867 REMARK 3 5 3.0403 - 2.8227 1.00 2733 136 0.1593 0.1833 REMARK 3 6 2.8227 - 2.6564 1.00 2693 172 0.1581 0.1854 REMARK 3 7 2.6564 - 2.5235 1.00 2700 133 0.1544 0.1790 REMARK 3 8 2.5235 - 2.4137 1.00 2710 125 0.1506 0.1736 REMARK 3 9 2.4137 - 2.3208 1.00 2689 130 0.1511 0.1834 REMARK 3 10 2.3208 - 2.2408 1.00 2693 152 0.1552 0.1904 REMARK 3 11 2.2408 - 2.1708 1.00 2688 141 0.1524 0.1883 REMARK 3 12 2.1708 - 2.1087 1.00 2695 123 0.1577 0.1996 REMARK 3 13 2.1087 - 2.0532 1.00 2706 132 0.1609 0.1954 REMARK 3 14 2.0532 - 2.0032 1.00 2693 128 0.1705 0.2275 REMARK 3 15 2.0032 - 1.9576 1.00 2673 129 0.1833 0.2018 REMARK 3 16 1.9576 - 1.9160 1.00 2701 133 0.1906 0.2292 REMARK 3 17 1.9160 - 1.8777 1.00 2677 136 0.2068 0.2263 REMARK 3 18 1.8777 - 1.8423 1.00 2675 133 0.2175 0.2646 REMARK 3 19 1.8423 - 1.8094 1.00 2699 131 0.2356 0.2617 REMARK 3 20 1.8094 - 1.7787 1.00 2634 137 0.2456 0.2797 REMARK 3 21 1.7787 - 1.7500 1.00 2666 158 0.2502 0.2807 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.12 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 2817 REMARK 3 ANGLE : 1.380 3818 REMARK 3 CHIRALITY : 0.093 424 REMARK 3 PLANARITY : 0.010 501 REMARK 3 DIHEDRAL : 10.940 1684 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5MUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1200002357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-SEP-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59814 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 78.878 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 18.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.26800 REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 18.00 REMARK 200 R MERGE FOR SHELL (I) : 0.79100 REMARK 200 R SYM FOR SHELL (I) : 0.79100 REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YLW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M KBR, 0.2M KSCN, 0.1M NAAC PH 5.2, REMARK 280 25% PEG 400, 2% PGA-LM, PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.68133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.84067 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.84067 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 81.68133 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 70 REMARK 465 ALA A 71 REMARK 465 ARG A 72 REMARK 465 SER A 214 REMARK 465 SER A 215 REMARK 465 PRO A 216 REMARK 465 ASN A 217 REMARK 465 THR A 218 REMARK 465 ALA A 219 REMARK 465 GLY A 220 REMARK 465 LEU A 221 REMARK 465 ARG A 222 REMARK 465 SER A 223 REMARK 465 LEU A 224 REMARK 465 GLN A 225 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 41 -62.90 -123.07 REMARK 500 ASP A 99 75.90 -115.39 REMARK 500 ALA A 104 22.97 -140.25 REMARK 500 LEU A 137 76.69 -118.12 REMARK 500 TYR A 356 -62.76 -141.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ORO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HYT A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 408 DBREF 5MUT A 32 396 UNP Q02127 PYRD_HUMAN 31 395 SEQRES 1 A 365 THR GLY ASP GLU ARG PHE TYR ALA GLU HIS LEU MET PRO SEQRES 2 A 365 THR LEU GLN GLY LEU LEU ASP PRO GLU SER ALA HIS ARG SEQRES 3 A 365 LEU ALA VAL ARG PHE THR SER LEU GLY LEU LEU PRO ARG SEQRES 4 A 365 ALA ARG PHE GLN ASP SER ASP MET LEU GLU VAL ARG VAL SEQRES 5 A 365 LEU GLY HIS LYS PHE ARG ASN PRO VAL GLY ILE ALA ALA SEQRES 6 A 365 GLY PHE ASP LYS HIS GLY GLU ALA VAL ASP GLY LEU TYR SEQRES 7 A 365 LYS MET GLY PHE GLY PHE VAL GLU ILE GLY SER VAL THR SEQRES 8 A 365 PRO LYS PRO GLN GLU GLY ASN PRO ARG PRO ARG VAL PHE SEQRES 9 A 365 ARG LEU PRO GLU ASP GLN ALA VAL ILE ASN ARG TYR GLY SEQRES 10 A 365 PHE ASN SER HIS GLY LEU SER VAL VAL GLU HIS ARG LEU SEQRES 11 A 365 ARG ALA ARG GLN GLN LYS GLN ALA LYS LEU THR GLU ASP SEQRES 12 A 365 GLY LEU PRO LEU GLY VAL ASN LEU GLY LYS ASN LYS THR SEQRES 13 A 365 SER VAL ASP ALA ALA GLU ASP TYR ALA GLU GLY VAL ARG SEQRES 14 A 365 VAL LEU GLY PRO LEU ALA ASP TYR LEU VAL VAL ASN VAL SEQRES 15 A 365 SER SER PRO ASN THR ALA GLY LEU ARG SER LEU GLN GLY SEQRES 16 A 365 LYS ALA GLU LEU ARG ARG LEU LEU THR LYS VAL LEU GLN SEQRES 17 A 365 GLU ARG ASP GLY LEU ARG ARG VAL HIS ARG PRO ALA VAL SEQRES 18 A 365 LEU VAL LYS ILE ALA PRO ASP LEU THR SER GLN ASP LYS SEQRES 19 A 365 GLU ASP ILE ALA SER VAL VAL LYS GLU LEU GLY ILE ASP SEQRES 20 A 365 GLY LEU ILE VAL THR ASN THR THR VAL SER ARG PRO ALA SEQRES 21 A 365 GLY LEU GLN GLY ALA LEU ARG SER GLU THR GLY GLY LEU SEQRES 22 A 365 SER GLY LYS PRO LEU ARG ASP LEU SER THR GLN THR ILE SEQRES 23 A 365 ARG GLU MET TYR ALA LEU THR GLN GLY ARG VAL PRO ILE SEQRES 24 A 365 ILE GLY VAL GLY GLY VAL SER SER GLY GLN ASP ALA LEU SEQRES 25 A 365 GLU LYS ILE ARG ALA GLY ALA SER LEU VAL GLN LEU TYR SEQRES 26 A 365 THR ALA LEU THR PHE TRP GLY PRO PRO VAL VAL GLY LYS SEQRES 27 A 365 VAL LYS ARG GLU LEU GLU ALA LEU LEU LYS GLU GLN GLY SEQRES 28 A 365 PHE GLY GLY VAL THR ASP ALA ILE GLY ALA ASP HIS ARG SEQRES 29 A 365 ARG HET FMN A 401 31 HET ORO A 402 11 HET HYT A 403 26 HET ACT A 404 4 HET ACT A 405 4 HET CL A 406 1 HET CL A 407 1 HET CL A 408 1 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM HYT 2-METHYL-5-OXIDANYL-~{N}-[2,3,5,6-TETRAKIS(FLUORANYL)- HETNAM 2 HYT 4-PHENYL-PHENYL]-1,2,3-TRIAZOLE-4-CARBOXAMIDE HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 ORO C5 H4 N2 O4 FORMUL 4 HYT C16 H10 F4 N4 O2 FORMUL 5 ACT 2(C2 H3 O2 1-) FORMUL 7 CL 3(CL 1-) FORMUL 10 HOH *301(H2 O) HELIX 1 AA1 THR A 32 HIS A 41 1 10 HELIX 2 AA2 HIS A 41 LEU A 50 1 10 HELIX 3 AA3 ASP A 51 LEU A 65 1 15 HELIX 4 AA4 SER A 76 GLU A 80 5 5 HELIX 5 AA5 ALA A 104 MET A 111 1 8 HELIX 6 AA6 PRO A 138 ASP A 140 5 3 HELIX 7 AA7 GLY A 153 ALA A 163 1 11 HELIX 8 AA8 ARG A 164 ASP A 174 1 11 HELIX 9 AA9 ASP A 190 GLY A 203 1 14 HELIX 10 AB1 PRO A 204 ALA A 206 5 3 HELIX 11 AB2 LYS A 227 GLY A 243 1 17 HELIX 12 AB3 ARG A 245 ARG A 249 5 5 HELIX 13 AB4 THR A 261 GLY A 276 1 16 HELIX 14 AB5 LEU A 309 THR A 324 1 16 HELIX 15 AB6 SER A 338 GLY A 349 1 12 HELIX 16 AB7 TYR A 356 GLY A 363 1 8 HELIX 17 AB8 PRO A 365 GLN A 381 1 17 HELIX 18 AB9 GLY A 385 ILE A 390 1 6 HELIX 19 AC1 GLY A 391 ARG A 396 5 6 SHEET 1 AA1 2 VAL A 81 VAL A 83 0 SHEET 2 AA1 2 HIS A 86 PHE A 88 -1 O PHE A 88 N VAL A 81 SHEET 1 AA2 9 VAL A 92 ILE A 94 0 SHEET 2 AA2 9 PHE A 115 VAL A 121 1 O PHE A 115 N ILE A 94 SHEET 3 AA2 9 LEU A 178 LEU A 182 1 O GLY A 179 N VAL A 116 SHEET 4 AA2 9 TYR A 208 VAL A 213 1 O VAL A 210 N LEU A 182 SHEET 5 AA2 9 ALA A 251 ILE A 256 1 O LYS A 255 N VAL A 213 SHEET 6 AA2 9 GLY A 279 VAL A 282 1 O ILE A 281 N VAL A 254 SHEET 7 AA2 9 ILE A 330 VAL A 333 1 O ILE A 331 N VAL A 282 SHEET 8 AA2 9 LEU A 352 LEU A 355 1 O LEU A 352 N GLY A 332 SHEET 9 AA2 9 VAL A 92 ILE A 94 1 N GLY A 93 O VAL A 353 SHEET 1 AA3 3 VAL A 134 LEU A 137 0 SHEET 2 AA3 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AA3 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 CISPEP 1 GLY A 119 SER A 120 0 6.35 CISPEP 2 ARG A 131 PRO A 132 0 -1.74 CISPEP 3 VAL A 282 THR A 283 0 11.89 SITE 1 AC1 26 ALA A 95 ALA A 96 GLY A 97 LYS A 100 SITE 2 AC1 26 GLY A 119 SER A 120 ASN A 145 TYR A 147 SITE 3 AC1 26 ASN A 181 ASN A 212 LYS A 255 THR A 283 SITE 4 AC1 26 ASN A 284 THR A 285 SER A 305 GLY A 306 SITE 5 AC1 26 LEU A 309 VAL A 333 GLY A 334 GLY A 335 SITE 6 AC1 26 LEU A 355 TYR A 356 THR A 357 ORO A 402 SITE 7 AC1 26 HOH A 520 HOH A 550 SITE 1 AC2 9 LYS A 100 ASN A 145 TYR A 147 GLY A 148 SITE 2 AC2 9 PHE A 149 ASN A 212 ASN A 284 THR A 285 SITE 3 AC2 9 FMN A 401 SITE 1 AC3 13 MET A 43 LEU A 46 GLN A 47 PRO A 52 SITE 2 AC3 13 ALA A 55 HIS A 56 ALA A 59 LEU A 67 SITE 3 AC3 13 LEU A 68 ARG A 136 LEU A 359 THR A 360 SITE 4 AC3 13 HOH A 565 SITE 1 AC4 6 ALA A 169 THR A 172 LEU A 205 ASP A 207 SITE 2 AC4 6 HOH A 533 HOH A 686 SITE 1 AC5 7 LYS A 307 PRO A 308 ASP A 311 THR A 314 SITE 2 AC5 7 GLN A 315 ARG A 318 HOH A 525 SITE 1 AC6 1 ARG A 136 SITE 1 AC7 4 GLN A 165 HIS A 248 ARG A 298 SER A 299 SITE 1 AC8 4 ARG A 245 GLY A 302 HOH A 672 HOH A 756 CRYST1 91.080 91.080 122.522 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010979 0.006339 0.000000 0.00000 SCALE2 0.000000 0.012678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008162 0.00000